Evidence map›Paper›PMID 24502234›Full record

ArticleJournal of the American Chemical Society2014

Design of sequence-specific DNA binding molecules for DNA methyltransferase inhibition.

JeenJoo S Kang, Jordan L Meier, Peter B Dervan

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Genomic targeting of epigenetic probes using a chemically tailored Cas9 system.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

JeenJoo S KangDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Jordan L Meier
Peter B Dervan

Funding

Targeting Cancer Through Modifications and MetabolismZIABC011488 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MEIER, JORDAN L · 2013 to 2025
$21.3M
SITE SPECIFIC CHEMICAL METHODS FOR CLEAVING GENOMIC DNAR01GM051747 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1995 to 2014
$6.2M
SEQUENCE SPECIFIC RECOGNITION OF DOUBLE HELICAL DNAR01GM027681 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1985 to 2017
$4.5M
SEQUENCE SPECIFIC RECOGNITION OF DNAR37GM027681 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1996 to 2005
$1.9M
NIGMS NIH HHS GM27681NIGMS NIH HHS GM51747NIGMS NIH HHS R01 GM027681NIGMS NIH HHS R01 GM051747NIGMS NIH HHS R37 GM027681
6 · The paper itself

Abstract

The CpG dyad, an important genomic feature in DNA methylation and transcriptional regulation, is an attractive target for small molecules. To assess the utility of minor groove binding oligomers for CpG recognition, we screened a small library of hairpin pyrrole-imidazole polyamides targeting the sequence 5'-CGCG-3' and assessed their sequence specificity using an unbiased next-generation sequencing assay. Our findings indicate that hairpin polyamide of sequence PyImβIm-γ-PyImβIm (1), previously identified as a high affinity 5'-CGCG-3' binder, favors 5'-GCGC-3' in an unanticipated reverse binding orientation. Replacement of one β alanine with Py to afford PyImPyIm-γ-PyImβIm (3) restores the preference for 5'-CGCG-3' binding in a forward orientation. The minor groove binding hairpin 3 inhibits DNA methyltransferase activity in the major groove at its target site more effectively than 1, providing a molecular basis for design of sequence-specific antagonists of CpG methylation.

Indexed as

Drug DesignBase SequenceCpG IslandsDNADNA (Cytosine-5-)-MethyltransferasesDNA MethylationEnzyme InhibitorsHigh-Throughput Screening AssaysImidazolesSubstrate SpecificityDNADNA (Cytosine-5-)-MethyltransferasesEnzyme InhibitorsImidazoles

Identifiers

PMID24502234
PMCPMC3985849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.